Skip to main content
. 2017 Sep 8;66(12):3085–3090. doi: 10.2337/db17-0551

Table 1.

Physical and metabolic characteristics in obese youth with IGT vs. NGT

NGT (n = 97) IGT (n = 41) P
Physical characteristics
 Age (years) 14.3 ± 0.2 14.7 ± 0.4 NS
 Sex (male/female), n (%) 35 (36)/62 (64) 9 (22)/32 (78) NS
 Race (AA/AW), n (%) 46 (47)/51 (53) 13 (32)/28 (68) NS
 Tanner stage (III/IV/V), n (%) 26 (27)/18 (18)/53 (55) 4 (10)/7 (17)/30 (73) NS
 BMI (kg/m2) 34.4 ± 0.6 36.9 ± 1.0 0.029
 BMI z score 2.20 ± 0.05 2.35 ± 0.05 0.018
 Total fat mass (kg) 38.5 ± 1.3 43.2 ± 1.7 0.046
 Fat-free mass (kg) 48.0 ± 1.0 51.0 ± 1.6 NS
 Percent body fat (%) 42.4 ± 0.8 44.5 ± 0.8 NS
 Total cholesterol (mg/dL) 161.6 ± 3.2 172.9 ± 5.1 NS
 Triglyceride (mg/dL) 116.2 ± 5.5 140.4 ± 13.7 NS
 HDL (mg/dL) 41.7 ± 0.9 38.2 ± 1.4 0.034
 LDL (mg/dL) 96.8 ± 2.9 106.9 ± 4.7 NS
 VLDL (mg/dL) 23.2 ± 1.1 26.1 ± 2.4 NS
Metabolic characteristics
 HbA1c (%) 5.26 ± 0.04 5.35 ± 0.07 NS
 Fasting glucose (mg/dL) 95.8 ± 0.6 97.5 ± 1.2 NS
 Fasting insulin (µU/mL) 35.6 ± 1.6 49.6 ± 4.6 0.002
 Fasting FFAs (mmol/L) 0.30 ± 0.01 0.35 ± 0.02 0.070
 Steady-state glucose (mg/dL) 100.6 ± 0.2 100.3 ± 0.3 NS
 Steady-state insulin (µU/mL) 283.5 ± 9.5 308.0 ± 13.4 NS
Hyperglycemic clamp parameters
 First-phase insulin concentration (µU/mL) 248.9 ± 19.6 219.3 ± 18.8 NS
 Second-phase insulin concentration (µU/mL) 285.5 ± 15.9 323.5 ± 28.7 NS

Values are reported as mean ± SEM or n (%). AA, African American; AW, American white.

HHS Vulnerability Disclosure